These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23220706)

  • 1. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury.
    Goto H; Nomiyama T; Mita T; Yasunari E; Azuma K; Komiya K; Arakawa M; Jin WL; Kanazawa A; Kawamori R; Fujitani Y; Hirose T; Watada H
    Biochem Biophys Res Commun; 2011 Feb; 405(1):79-84. PubMed ID: 21215253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
    Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
    J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
    Jensen EP; Poulsen SS; Kissow H; Holstein-Rathlou NH; Deacon CF; Jensen BL; Holst JJ; Sorensen CM
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F867-77. PubMed ID: 25656368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells.
    Takahashi H; Nomiyama T; Terawaki Y; Kawanami T; Hamaguchi Y; Tanaka T; Tanabe M; Bruemmer D; Yanase T
    J Atheroscler Thromb; 2019 Feb; 26(2):183-197. PubMed ID: 29962378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
    Nagayama K; Kyotani Y; Zhao J; Ito S; Ozawa K; Bolstad FA; Yoshizumi M
    PLoS One; 2015; 10(9):e0137960. PubMed ID: 26379274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
    Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
    Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A
    Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.
    Ma X; Meng J; Jia M; Bi L; Zhou Y; Wang Y; Hu J; He G; Luo X
    J Bone Miner Res; 2013 Jul; 28(7):1641-52. PubMed ID: 23427056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
    Lim S; Lee GY; Park HS; Lee DH; Tae Jung O; Kyoung Min K; Kim YB; Jun HS; Hak Chul J; Park KS
    Cardiovasc Res; 2017 Feb; 113(2):183-194. PubMed ID: 27702762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
    Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
    Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
    Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
    Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
    Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.